{{Drugbox
| verifiedrevid = 458298378
| IUPAC_name = (2''S'',5''R'',6''R'')-6-{[3-(2,6-dichlorophenyl)-5-methyl-<br />oxazole-4-carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-<br />1-azabicyclo[3.2.0]heptane-2-carboxylic acid
| image = Dicloxacillin.svg
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|monograph|dicloxacillin-sodium}}
| MedlinePlus = a685017
| pregnancy_AU = B2
| pregnancy_US = B
| legal_AU = S4
| legal_US = Rx-only
| routes_of_administration = Oral
<!--Pharmacokinetic data-->
| bioavailability = 60 to 80%
| protein_bound = 98%
| metabolism = [[Liver|Hepatic]]
| elimination_half-life = 0.7 hours
| excretion = [[Kidney|Renal]] and biliary
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 3116-76-5
| ATC_prefix = J01
| ATC_suffix = CF01
| ATC_supplemental =  {{ATCvet|J51|CF01}}
| PubChem = 18381
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00485
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 17358
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = COF19H7WBK
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02348
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 4511
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 893
<!--Chemical data-->
| C=19 | H=17 | Cl=2 | N=3 | O=5 | S=1
| molecular_weight = 470.327 g/mol
| SMILES = O=C(O)[C@@H]3N4C(=O)[C@@H](NC(=O)c2c(onc2c1c(Cl)cccc1Cl)C)[C@H]4SC3(C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H17Cl2N3O5S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28)/t13-,14+,17-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = YFAGHNZHGGCZAX-JKIFEVAISA-N
}}
'''Dicloxacillin''' is a [[Narrow-spectrum antibiotic|narrow-spectrum]] [[β-lactam antibiotic]] of the [[penicillin]] class.<ref name=":0" /> It is used to treat infections caused by susceptible (non-resistant) [[Gram-positive bacteria]].<ref name=":0">Product Information: DICLOXACILLIN SODIUM-dicloxacillin sodium capsule. Teva Pharmaceuticals USA Inc, Revised 8/2015</ref> It is active against [[beta-lactamase]]-producing organisms such as ''[[Staphylococcus aureus]]'', which would otherwise be resistant to most [[penicillin]]s. Dicloxacillin is available under a variety of trade names including Diclocil ([[Bristol-Myers Squibb|BMS]]).<ref>{{cite journal|last1=Miranda-Novales|first1=G|last2=Leaños-Miranda|first2=BE|last3=Vilchis-Pérez|first3=M|last4=Solórzano-Santos|first4=F|title=In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.|journal=Annals of Clinical Microbiology and Antimicrobials|date=12 October 2006|volume=5|pages=25|pmid=17034644|doi=10.1186/1476-0711-5-25|pmc=1617116}}</ref>

==Medical uses==
Dicloxacillin is used to treat mild-to-moderate staphylococcal infections.<ref name="rossi">"Dicloxacillin".&nbsp;''livertox.nih.gov''. Retrieved&nbsp;2015-11-05.</ref> To decrease the development of resistance, dicloxacillin is recommended to treat infections that are suspected or proven to be caused by beta-lactamase-producing bacteria.<ref name="rossi" />

Dicloxacillin is similar in [[pharmacokinetics]], antibacterial activity, and indications to flucloxacillin, and the two agents are considered interchangeable.<ref name=":1">Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006</ref> It is believed to have lower incidence of severe hepatic [[adverse effect (medicine)|adverse effects]] than flucloxacillin, but a higher incidence of renal adverse effects.<ref name=":1" />

Dicloxacillin is used for the treatment of infections caused by susceptible bacteria. Specific approved indications include:<ref name=":1" /> 
*[[Staphylococcus|Staphylococcal skin infections]] and [[cellulitis]] – including [[impetigo]], [[otitis externa]], [[folliculitis]], [[boil]]s, [[carbuncles]], and [[mastitis]]
*[[Pneumonia]] (adjunct)
*[[Osteomyelitis]], [[septic arthritis]], throat infections, streptococcus
*[[Septicaemia]]
*[[Empirical]] treatment for [[endocarditis]]
*Surgical [[prophylaxis]]

===Available forms===
Dicloxacillin is commercially available as the sodium salt, '''dicloxacillin sodium,''' in [[Capsule (pharmacy)|capsules]] and as a powder for reconstitution.<ref name=":0" /><ref>"Dicloxacillin: MedlinePlus Drug Information".&nbsp;''www.nlm.nih.gov''. Retrieved&nbsp;2015-11-05.</ref>

==Contraindications==
Dicloxacillin is contraindicated in those with a previous history of allergy (hypersensitivity/[[Anaphylaxis|anaphylactic]] reaction) to any penicillins.<ref name=":0" /><ref>"DailyMed - DICLOXACILLIN SODIUM- dicloxacillin sodium capsule".&nbsp;''dailymed.nlm.nih.gov''. Retrieved&nbsp;2015-11-05.</ref>

==Adverse effects==
Common [[adverse drug reaction]]s (ADRs) associated with the use of dicloxacillin include: [[diarrhoea]], [[nausea]], [[rash]], [[urticaria]], [[pain]] and [[inflammation]] at injection site, [[superinfection]] (including [[candidiasis]]), [[allergy]], and transient increases in liver enzymes and bilirubin.<ref name=":1" />

On rare occasions, [[cholestasis|cholestatic jaundice]] (also referred to as cholestatic hepatitis) has been associated with dicloxacillin therapy. The reaction may occur up to several weeks after treatment has stopped, and takes weeks to resolve. The estimated incidence is 1 in 15,000 exposures, and is more frequent in people over 55 years old, females, and those with treatment longer than 2 weeks.<ref name=":1" />

It should be used with caution and monitored in the elderly, particularly with intravenous administration, due to a risk of [[thrombophlebitis]].<ref name=":0" />

=== Interactions ===
Dicloxacillin has potential interactions with following drugs:
* Warfarin<ref>{{cite journal|last1=Lacey|first1=CS|title=Interaction of dicloxacillin with warfarin.|journal=The Annals of pharmacotherapy|date=May 2004|volume=38|issue=5|pages=898|pmid=15054148|doi=10.1345/aph.1d484}}</ref>
* Methotrexate<ref>{{cite journal|last1=Ronchera|first1=CL|last2=Hernández|first2=T|last3=Peris|first3=JE|last4=Torres|first4=F|last5=Granero|first5=L|last6=Jiménez|first6=NV|last7=Plá|first7=JM|title=Pharmacokinetic interaction between high-dose methotrexate and amoxycillin.|journal=Therapeutic drug monitoring|date=October 1993|volume=15|issue=5|pages=375–9|pmid=8249043|doi=10.1097/00007691-199310000-00004}}</ref>
* Tetracyclines<ref>{{cite journal|last1=Moellering RC|first1=Jr|title=Rationale for use of antimicrobial combinations.|journal=The American Journal of Medicine|date=29 August 1983|volume=75|issue=2A|pages=4–8|pmid=6351605}}</ref>

==Resistance==
Despite dicloxacillin being insensitive to beta-lactamases, some organisms have developed resistance to other narrow-spectrum β-lactam antibiotics including methicillin. Such organisms include [[Methicillin-resistant Staphylococcus aureus|methicillin-resistant ''Staphylococcus aureus'']] (MRSA).<ref>{{cite journal|last1=Rosdahl|first1=VT|last2=Frimodt-Møller|first2=N|last3=Bentzon|first3=MW|title=Resistance to dicloxacillin, methicillin and oxacillin in methicillin-susceptible and methicillin-resistant Staphylococcus aureus detected by dilution and diffusion methods.|journal=APMIS : acta pathologica, microbiologica, et immunologica Scandinavica|date=August 1989|volume=97|issue=8|pages=715–22|pmid=2669854}}</ref>{{Better source|reason=This source explicitly says all MRSA strains they tested were susceptible to dicloxacillin. MRSA by itself is not relevant to this article. We need a source about dicloxacillin resistance.|date=October 2017}}

==Mechanism of action==
{{main article|β-Lactam antibiotic}}

Like other β-lactam antibiotics, dicloxacillin acts by inhibiting the synthesis of bacterial [[cell wall]]s. It inhibits cross-linkage between the linear [[peptidoglycan]] polymer chains that make up a major component of the cell wall of [[Gram-positive]] bacteria.

==Medicinal chemistry==
Dicloxacillin is insensitive to [[beta-lactamase]] (also known as penicillinase) enzymes secreted by many penicillin-resistant bacteria. The presence of the [[isoxazole|isoxazolyl]] group on the side chain of the penicillin nucleus facilitates the β-lactamase resistance, since they are relatively intolerant of side-chain [[steric hindrance]]. Thus, it is able to bind to [[penicillin-binding protein]]s (PBPs) and inhibit [[peptidoglycan]] crosslinking, but is not bound by or inactivated by β-lactamase

==See also==
*[[Beta-lactam antibiotic]]
*[[Flucloxacillin]]
*[[Amoxicillin]] (formerly [[Beecham (pharmaceutical company)|Beecham]], now [[GlaxoSmithKline]])

==References==
<references/>

{{PenicillinAntiBiotics}}
{{Xenobiotic-sensing receptor modulators}}

[[Category:Penicillins]]
[[Category:Enantiopure drugs]]
[[Category:Isoxazoles]]
[[Category:Chloroarenes]]